Back to search
Circulating Markers
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Circulating Markers trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Circulating Markers trials you may qualify forEclectic is a strategy trial; once the class of treatment (endocrine therapy or chemotherapy) has been allocated according to 16α-18F-fluoro-17β-oestradiol (18F…
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments…
The purpose of the study is to assess the effect of zigakibart on IgA nephropathy (IgAN) disease progression.
This clinical trial aims to evaluate the effectiveness of tirzepatide in achieving a 5% or more body weight reduction in patients undergoing adjuvant treatment…
Radiotherapy (RT) is a well-known and established therapy or adjuvant therapy for the treatment of thoracic cancer It uses a high energy radiation from x-rays,…
The primary objective is to investigate the impact of milk, fermented milk, and soy beverages, incorporated in a diet reflecting adherence to Canadian food guid…
Each year, approximately 69 million people worldwide suffer from traumatic brain injuries (TBI), representing a significant burden on public health, society, an…
Experimental models have linked lipid lowering therapies with systemic inflammation; however, relatively little is known about this network in clinical populati…
The chemotherapy monitoring is currently based on radiological (RECIST 1.1 guideline) and clinical evaluation every 3 months. Circulating markers as Carcino Emb…